The Herbert and Florence Irving Institute for Cancer Dynamics will continue its seminar series on the topic of mathematical sciences underpinning cancer research. The monthly seminars take place on the second Wednesday of the month, 2:00-3:00 PM EST. The presentations are open to the Columbia community (in person and online) and to researchers outside Columbia (via Zoom).
On Wednesday, January 14th (2:00 PM ET), IICD welcomes Dr. Matthew G. Jones from MIT. Seminar hosted by Dr. Jellert Gaublomme. The seminar will take place in person in Schermerhorn Hall 603 (Morningside Heights campus). If you wish to attend the seminar remotely, please register using the following link: https://columbiauniversity.zoom.us/meeting/register/8BKD8L-xQZWOaZlQ6Kz6qQ
Title: Quantitatively Profiling Tumor Evolution Beyond Chromosomes
Abstract: Oncogene amplification on extrachromosomal DNA (ecDNA) is a common driver of tumor progression, where it is associated with acquired drug resistance and poor patient survival. While whole genome sequencing (WGS) studies have revealed the landscape of genes amplified on ecDNA in tumors, it has remained challenging to study the dynamics and phenotypic consequences of ecDNA on tumors. In this seminar, I will present our recent work integrating high-resolution genomic technologies and computational tools to dissect the single-cell dynamics of ecDNA. These studies have given new insight into the complex copy-number dynamics of ecDNA over time (including in drug resistant disease) and the molecular consequences of ecDNA in patient tumors. Together, we hope these findings and tools will broadly enable several studies - both retrospective and prospective - that dissect critical questions of how ecDNA affect cancer cells and the tumors in which they reside.
Bio: Matt Jones is an Assistant Professor at MIT in the Department of Biology and core member of the Koch Institute for Integrative Cancer Research and the Institute for Medical Science & Engineering. Previously, Matt earned his PhD at UCSF, where he developed computational approaches for single-cell lineage-tracing technologies and evolutionary approaches to study cancer dynamics. He then performed postdoctoral work at Stanford University, where he pursued fundamental studies on extrachromosomal DNA — circular, megabase-scale DNA amplifications found across cancers and associated with poor patient survival, drug resistance, and metastasis. Currently, his lab aims to develop innovative computational and technological approaches to uncover mechanisms of tumor evolution, identify new therapeutic targets, and create predictive models to monitor tumor initiation and progression. They integrate computation with multiomic approaches, lineage tracing, and high-resolution imaging to investigate the spatiotemporal dynamics of copy-number alterations, particularly extrachromosomal DNA, and elucidate the principles by which tumors are organized over time. You can read more about his lab here.
If you would like to meet one-on-one (possibly via Zoom) or attend the lunch or dinner with the speaker, please contact the event organizer.